Cloned (Comment) | Organism |
---|---|
recombinant expression of wild-type and mutant C-terminally human serum albumin-fused extracellular domains of human NEP (amino acids 52-749) in CHO cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
E584V | site-directed mutagenesis, inactive mutant, has no effects on prothrombin time (PT) and activated partial thromboplastin time (APTT) in rats and monkeys | Homo sapiens |
G399V/G714K | site-directed mutagenesis, the engineered NEP, HSA-NEPv G399V/G714K, has a potential as therapeutic for Alzheimer disease but in pre-clinical safety testing, this variant increases prothrombin time (PT) and activated partial thromboplastin time (APTT) measured in cynomolgus monkeys and rats dosed with a human serum albumin fusion with an engineered variant of NEP as well as in control plasma spiked with wild-type or mutant enzyme. Wild-type HSA-NEP and mutant HSA-NEPv impair coagulation, increasing PT and APTT in plasma samples and abolishing fibrin formation from fibrinogen. This effect is mediated through cleavage of the N-termini of the Aalpha- and Bbeta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin. The effects on PT and APTT are broadly similar in male and female rats although the effect on APTT is less clear cut in females | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
fibrinogen + H2O | Homo sapiens | inactivation, mechanism of NEP-mediated inactivation of fibrinogen through cleavage of the N-termini of the Aalpha- and Bbeta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin, overview | fibrin + ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P08473 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutant C-terminally human serum albumin-fused extracellular domains of human NEP (amino acids 52-749) from CHO cells by affinity chromatography | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
fibrinogen + H2O | inactivation, mechanism of NEP-mediated inactivation of fibrinogen through cleavage of the N-termini of the Aalpha- and Bbeta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin, overview | Homo sapiens | fibrin + ? | - |
? | |
fibrinogen + H2O | fibrinogen from human and rat blood plasma, inactivation | Homo sapiens | fibrin + ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
NEP | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | neprilysin inhibits coagulation through proteolytic inactivation of fibrinogen. The enzyme may have a role in regulating fibrin formation. Wild-type HSA-NEP and mutant HSA-NEPv impair coagulation, increasing prothrombin time (PT) and activated partial thromboplastin time (APTT) in plasma samples and abolishing fibrin formation from fibrinogen. This effect is mediated through cleavage of the N-termini of the Aalpha- and Bbeta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin | Homo sapiens |